PTC Therapeutics said it cannot resolve differences it has with the FDA in interpreting clinical trial data for Translarna, a drug it developed for Duchenne muscular dystrophy. The rare disease drug develop...
Subscribe to MedCity News’s news feed.
Click on “Follow” and decide if you want to get news from MedCity News via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to MedCity News comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from MedCity News which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: MedCity News - Healthcare technology news, life science current events